1.Macrolide Resistance Trends in beta-Hemolytic Streptococci in a Tertiary Korean Hospital.
Young UH ; Gyu Yel HWANG ; In Ho JANG ; Hyun Mi CHO ; Song Mi NOH ; Hyo Youl KIM ; Ohgun KWON ; Kap Jun YOON
Yonsei Medical Journal 2007;48(5):773-778
PURPOSE: Erythromycin-resistant beta-hemolytic streptococci (BHS) has recently emerged and quickly spread between and within countries throughout the world. In this study, we evaluate the antimicrobial susceptibility patterns and erythromycin resistance mechanisms of BHS during 2003-2004. MATERIALS AND METHODS: The MICs of seven antimicrobials were determined for 204 clinical isolates of BHS from 2003 to 2004. Resistance mechanisms of erythromycin-resistant BHS were studied by the double disk test as well as by polymerase chain reaction (PCR). RESULTS: Compared with our previous study, resistance among Streptococcus pyogenes isolates to a variety of drugs decreased strikingly: from 25.7% to 4.8% in erythromycin; 15.8% to 0% in clindamycin; and 47.1% to 19.0% in tetracycline. The prevalent phenotypes and genotypes of macrolide-lincosamide-streptograminB (MLSB) resistance in Streptococcus pyogenes isolates have been changed from the constitutive MLSB phenotype carrying erm(B) to the M phenotype with mef(A) gene. In contrast with Streptococcus pyogenes, resistance rates to erythromycin (36.7%), clindamycin (43.1%), and tetracycline (95.4%) in Streptococcus agalactiae isolates did not show decreasing trends. Among the Streptococcus dysgalactiae subsp. equisimilis isolates (Lancefield group C, G), resistance rates to erythromycin, clindamycin, tetracycline and chloramphenicol were observed to be 9.4%, 3.1%, 68.8%, and 9.4%, respectively. CONCLUSION: Continual monitoring of antimicrobial resistance among large-colony-forming BHS is needed to provide the medical community with current data regarding the resistance mechanisms that are most common to their local or regional environments.
Anti-Bacterial Agents/*pharmacology
;
Drug Resistance, Multiple, Bacterial
;
Erythromycin/*pharmacology
;
Genes, Bacterial
;
Genotype
;
Hospitals
;
Humans
;
Incidence
;
Korea
;
Microbial Sensitivity Tests
;
Streptococcus/*drug effects/genetics/isolation & purification
;
Streptococcus agalactiae/drug effects/genetics/isolation & purification
;
Streptococcus pyogenes/drug effects/genetics/isolation & purification
2.Neonatal group B streptococcus infection in the Children's Hospital of Gansu Province through PCR array.
Jing YANG ; Ding XU ; Li-qin YIN ; Bao-quan ZHU ; Ai-hua WANG
Chinese Journal of Pediatrics 2013;51(9):688-691
OBJECTIVETo study neonatal Streptococcus agalactiae (GBS) infection in The Children's Hospital of Gansu Province through Polymerase Chain Reaction(PCR) Array.
METHODAfter obtaining the informed consent from parents or guardians, blood samples of 286 neonates were collected and studied in The Children's Hospital of Gansu Province from June 2011 to January 2012. DNA of the selected samples was extracted through the method of 5% Chelex-100 + 0.5% NP40 solution. Twenty-five genes were ultimately selected and then 25 pairs of primers were designed respectively through primer-BLAST tool of NCBI database.For every primer, PCR conditions were optimized through the identified GBS, and 25 pairs of primers were arrayed as to be used to study neonatal GBS infection.
RESULTThe results of PCR Array showed that the 14 samples were detected positive, accounting for 4.90% of all the selected specimens. As for neonatal GBS infection, the positive rate was 4.55% within 7 days after birth and 5.19% in those older than 7 days. The positive rate of 53 preterm infants was 5.66%. The follow-up survey showed that none of the cases died.
CONCLUSIONIn the Children's Hospital of Gansu Province neonatal GBS infection rate was 4.90%, which is similar to the previous domestic reports, but is lower than the reports from Europe and the United States.Studies have shown that the gene expression related to immune evasion has a higher frequency. The present study suggests that the strategy of GBS immune adaptation may play an important role in neonatal GBS infection.
Bacterial Proteins ; genetics ; China ; epidemiology ; DNA Primers ; DNA, Bacterial ; genetics ; Female ; Gene Amplification ; Hospitals, Pediatric ; Humans ; Infant, Newborn ; Infant, Newborn, Diseases ; diagnosis ; epidemiology ; microbiology ; Male ; Polymerase Chain Reaction ; Sensitivity and Specificity ; Streptococcal Infections ; diagnosis ; epidemiology ; microbiology ; Streptococcus agalactiae ; genetics ; isolation & purification
3.Usefulness of a Rapid Real-time PCR Assay in Prenatal Screening for Group B Streptococcus Colonization.
Jeong Su PARK ; Dong Hee CHO ; Jae Hyug YANG ; Moon Young KIM ; Son Moon SHIN ; Eui Chong KIM ; Sung Sup PARK ; Moon Woo SEONG
Annals of Laboratory Medicine 2013;33(1):39-44
BACKGROUND: Group B streptococcus (GBS) infection is a leading cause of neonatal morbidity and mortality worldwide. Here, we present the analytical and diagnostic usefulness of a new real-time PCR-based assay (Xpert GBS; Cepheid, USA) for rapid and accurate prenatal GBS screening. METHODS: We enrolled 175 pregnant women who were between 35 and 39 weeks of gestation. The analytical performance of the Xpert GBS assay was first tested using a reference GBS strain. Next, to test diagnostic performance, rectovaginal swabs were obtained from pregnant women who visited the hospital for regular antenatal screening after 34 weeks of gestation. The results of the Xpert GBS assay were compared to those of standard culture for the detection of prenatal GBS colonization. RESULTS: When any positive result from Xpert GBS or culture was considered a true positive, the sensitivity of the Xpert GBS assay and culture were 91% (20/22; 95% CI [confidence interval], 72-98) and 68% (15/22; 95% CI, 47-84), respectively. The specificity of both methods was 100% (153/153; 95% CI, 97-100). The sensitivity and specificity of the Xpert GBS assay, using the culture results as a reference, were 86.7% and 95.6%, respectively. In the Xpert GBS assay, the median threshold cycle of vaginally colonized samples was significantly lower than rectally colonized samples (P<0.01). CONCLUSIONS: The Xpert GBS assay is an accurate, rapid, easy-to-use test for the detection of maternal GBS colonization in prenatal screening that might be especially useful in clinical settings where standard culture is not feasible.
DNA, Bacterial/*analysis
;
Female
;
Gestational Age
;
Humans
;
Pregnancy
;
Pregnancy Complications, Infectious/*diagnosis/microbiology
;
Prenatal Diagnosis
;
Reagent Kits, Diagnostic
;
Real-Time Polymerase Chain Reaction
;
Rectum/microbiology
;
Sensitivity and Specificity
;
Streptococcal Infections/*diagnosis/microbiology
;
Streptococcus agalactiae/*genetics/isolation & purification
;
Vagina/microbiology